Madrigal Pharmaceuticals (MDGL) Cash & Equivalents (2010 - 2026)
Madrigal Pharmaceuticals' Cash & Equivalents was $292.73 million in Q2 2026, up 57.2% from $186.19 million a year earlier and up 28.9% from the prior quarter.
Powered by 
Analysis
Madrigal Pharmaceuticals (MDGL) Cash & Equivalents (2010 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Madrigal Pharmaceuticals came in at $198.69 million, up 98.7% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 29.8% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $100.02 million in FY2024 (+0.1%), $99.92 million in FY2023 (-69.9%), $331.55 million in FY2022 (+814.1%) and $36.27 million in FY2021 (-32.8%).
- Quarterly Cash & Equivalents has moved between $36.27 million (Q4 2021) and $622.52 million (Q1 2024) over five years.
- Compared with a year earlier, Cash & Equivalents has increased for four straight quarters, with growth averaging 43.6% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2022 (growth of 814.1%); the worst was Q1 2025 (a decline of 70.5%).
- Per Business Quant data, MDGL's Cash & Equivalents in the three quarters before Q2 2026 was $227.03 million (Q1 2026), $198.69 million (Q4 2025) and $295.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Madrigal Pharmaceuticals | 14.56 Bn | 10.82 Bn | - | 292.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 292.73 Mn |
| Mar 31, 2026 | 227.03 Mn |
| Dec 31, 2025 | 198.69 Mn |
| Sep 30, 2025 | 295.69 Mn |
| Jun 30, 2025 | 186.19 Mn |
| Mar 31, 2025 | 183.65 Mn |
| Dec 31, 2024 | 100.02 Mn |
| Sep 30, 2024 | 232.68 Mn |
| Jun 30, 2024 | 494.60 Mn |
| Mar 31, 2024 | 622.52 Mn |
| Dec 31, 2023 | 99.92 Mn |
| Sep 30, 2023 | 62.06 Mn |
| Jun 30, 2023 | 77.20 Mn |
| Mar 31, 2023 | 113.31 Mn |
| Dec 31, 2022 | 331.55 Mn |
| Sep 30, 2022 | 59.34 Mn |
| Jun 30, 2022 | 53.27 Mn |
| Mar 31, 2022 | 42.28 Mn |
| Dec 31, 2021 | 36.27 Mn |
| Sep 30, 2021 | 49.17 Mn |
API Access
Madrigal Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MDGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MDGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MDGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();